Provider barriers to prescribing HAART to medically-eligible HIV-infected drug users
- 1 May 2004
- journal article
- Published by Taylor & Francis in AIDS Care
- Vol. 16 (4) , 485-500
- https://doi.org/10.1080/09540120410001683411
Abstract
We aimed to identify factors associated with a medical provider's resistance to prescribing HAART to medically-eligible HIV-infected illicit drug users. In four US cities, a mailed, self-administered survey queried 420 HIV care providers about patients' characteristics and barriers to care. Adjusted odds ratios (AOR) and 95% confidence intervals (CI) were estimated using logistic regression. Providers identified as resistant to prescribing HAART to medically-eligible HIV-infected illicit drug users were more likely to be non-physicians (AOR=1.89, 95% CI: 1.04-3.46), to work in populations with a high prevalence of both mental illness (AOR=2.42; 95% CI: 1.11-5.26) and injection drug use (AOR=1.82 95% CI: 1.02-3.25) and were deterred from prescribing HAART by patients' limited ability to keep appointments, (AOR=3.19; 95% CI: 1.39-7.37), alcoholism (AOR=1.92; 95% CI: 1.04-3.55) and homelessness (AOR=1.81; 95% CI: 1.07-3.06). Providers working in populations with a high injection drug use prevalence commonly reported higher prevalence of non-injection drug use, alcohol problems and mental illness, and higher antiretroviral therapy refusal rates within their patient populations. Our findings underscore the challenges to providers who treat HIV-infected drug users and suggest that their care and treatment would benefit from on-site drug treatment, mental health and social services.Keywords
This publication has 49 references indexed in Scilit:
- Impact of Antiretroviral Therapy on Decreasing Hospitalization Rates of HIV-Infected Patients in 2001AIDS Research and Human Retroviruses, 2002
- Directly Observed Therapy for the Treatment of People with Human Immunodeficiency Virus Infection: A Work in ProgressClinical Infectious Diseases, 2002
- Effectiveness of highly active antiretroviral therapy among HIV-1 infected womenJournal of Epidemiology and Community Health, 2002
- Management of Psychiatric Disorders in Patients Infected with Human Immunodeficiency VirusClinical Infectious Diseases, 2001
- Detrimental Effects of Continued Illicit Drug Use on the Treatment of HIV-1 InfectionJAIDS Journal of Acquired Immune Deficiency Syndromes, 2001
- Should physicians withhold highly active antiretroviral therapies from HIV-AIDS patients who are thought to be poorly adherent to treatment?AIDS, 2001
- Combination antiretroviral therapy: Health care providers confront emerging dilemmasAIDS Care, 2000
- Adherence to HAART in French HIV-infected injecting drug users: the contribution of buprenorphine drug maintenance treatmentAIDS, 2000
- Modified Directly Observed Therapy for Treatment of Human Immunodeficiency VirusPublished by American Medical Association (AMA) ,1999
- Physicians' Experience with the Acquired Immunodeficiency Syndrome as a Factor in Patients' SurvivalNew England Journal of Medicine, 1996